Synthesis and Anti-Inflammatory Activity of 1-Methylhydantoin Cinnamoyl Imides

Molecules. 2022 Dec 2;27(23):8481. doi: 10.3390/molecules27238481.

Abstract

In this study, 1-methylhydantoin cinnamic imides were synthesized from 1-methylhydantoin and trans-cinnamic acid, and their anti-inflammatory activity was investigated. The anti-inflammatory activity in vitro was evaluated by measuring the contents of NO, TNF-α and IL-1β in the supernatant of RAW264.7 cells stimulated by LPS. The cytotoxicity of 1-methylhydantoin cinnamoyl imides on RAW264.7 cells was detected using the CCK-8 method. The results showed that compounds 2 and 4 can significantly inhibit the release of NO and reduce the secretion of TNF-α and IL-1β. Compound 3 inhibited the production of TNF-α. The inhibition rate of COX was evaluated in vitro. The in vivo anti-inflammatory activities of the five compounds were evaluated by establishing an animal model of xylene ear swelling. The results showed that 1-methylhydantoin cinnamic imides could alleviate xylene-induced ear edema in mice in a dose-dependent manner. Among them, the effect of compound 5 was the most significant. Under the action of high dosage, its ear swelling inhibition rate was as high as 52.08%.

Keywords: 1-Methylhydantoin; Oviductus Ranae; inflammatory; natural product; trans-cinnamic acid.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Edema / chemically induced
  • Edema / drug therapy
  • Imides* / therapeutic use
  • Lipopolysaccharides / adverse effects
  • Mice
  • Plant Extracts / pharmacology
  • RAW 264.7 Cells
  • Tumor Necrosis Factor-alpha* / adverse effects

Substances

  • Tumor Necrosis Factor-alpha
  • Imides
  • Plant Extracts
  • Anti-Inflammatory Agents
  • Lipopolysaccharides